Results 41 to 50 of about 4,582,351 (335)

Magnitude of hemorrhagic complications and its associated factors among patients on anticoagulant therapy at University of Gondar Comprehensive and Specialized Hospital, Northwest Ethiopia

Thrombosis Update, 2023
Background: Despite the well-established effectiveness of anticoagulants, the risk of their hemorrhagic complications withheld many patients from being maintained on anticoagulant therapy. However, there is no sufficient data on the magnitude and factors
Eden Abetu Mehari, Abebe Basazn Mekuria, Mestayet Geta, Eshetie Melese Birru   +3 more
doaj  

Potential of anticoagulant therapy in cardiology practice for thrombocytopenia. Literature review

Российский кардиологический журнал, 2023
The review article discusses the issues of anticoagulant therapy in cardiovascular patients with thrombocytopenia (TP), gives the concept of ethylenediaminetetraacetic acidand heparin-induced TP.
K. G. Pereverzeva, S. S. Yakushin, A. An. Korshikova   +2 more
doaj   +1 more source

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage

Рациональная фармакотерапия в кардиологии, 2021
Intracerebral hemorrhage (ICH) is severe and fatal complication of anticoagulant therapy with an incidence 0.3-0.7% per year. For patients with atrial fibrillation (AF) anticoagulants are administered for decreasing risk of stroke and systemic embolism ...
A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov   +3 more
doaj   +1 more source

Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement

Critical Care, 2019
There is a high degree of uncertainty regarding optimum care of patients with potential or known intake of oral anticoagulants and traumatic brain injury (TBI).
M. Wiegele, H. Schöchl, A. Haushofer, M. Ortler, J. Leitgeb, O. Kwasny, R. Beer, C. Ay, E. Schaden   +8 more
semanticscholar   +1 more source

Management and Anticoagulation Treatment of Non-Valvular Atrial Fibrillation in Elderly Patients: The Dali Study

International Journal of General Medicine, 2023
Hong Huang, Nai-Qing Hu, Jun-Yun Yang, Yu-Luan Xiang, Yuan-Zhao Zhu, Qian-Ru Du, Xue-Yan Yin, Jin-lin Lv, Li-Hua Li Department of Gerontology, The First Affiliated Hospital of Dali University, Dali, Yunnan Province, 671000, People’s Republic of ...
Huang H, Hu NQ, Yang JY, Xiang YL, Zhu YZ, Du QR, Yin XY, Lv JL, Li LH   +8 more
doaj  

Bridging therapy according to new clinical guidelines: A review

Consilium Medicum, 2022
In modern world it is really important to know how to manage patients taking anticoagulant or antiplatelet therapy. There is an increasing number of patients, who have gone through PCI or any other cardiac intervention and who also need another surgery ...
Tatiana A. Pavlenko, Anastasiya Yu. Lebedeva, Denis N. Protsenko   +2 more
doaj   +1 more source

Anticoagulant therapy in acute respiratory distress syndrome.

Annals of Translational Medicine, 2018
Acute respiratory distress syndrome (ARDS) presents a complex pathophysiology characterized by pulmonary activated coagulation and reduced fibrinolysis.
M. Camprubí‐Rimblas, Neus Tantinyà, J. Bringué, R. Guillamat-Prats, A. Artigas   +4 more
semanticscholar   +1 more source

How to define the relative contraindications to oral anticoagulant therapy

Monaldi Archives for Chest Disease, 2017
There is currently a lack of consensus on which anticoagulant therapy contraindications should be considered “absolute” and which should be considered “relative”. Guidelines do not clearly identify absolute and relative contraindications to anticoagulant
Roberto F.E. Pedretti
doaj   +1 more source

D-dimer trends predict recurrent stroke in patients with cancer-related hypercoagulability

Cerebrovascular Diseases Extra, 2023
Introduction: In patients with cancer-associated hypercoagulability (CAH)-related stroke, D-dimer trends after anticoagulant therapy may offer a biomarker of treatment efficacy.
Jun Fujinami, Yoshinari Nagakane, Kei Fujikawa, Shohei Murata, Keiko Maezono, Tomoyuki Ohara, Toshiki Mizuno   +6 more
doaj   +1 more source

Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan

Critical Care, 2016
BackgroundLittle evidence supports anticoagulant therapy as effective adjuvant therapy to reduce mortality overall in sepsis. However, several studies suggest that anticoagulant therapy may reduce mortality in specific patients.
K. Yamakawa, Y. Umemura, M. Hayakawa, D. Kudo, M. Sanui, Hiroki Takahashi, Yoshiaki Yoshikawa, T. Hamasaki, S. Fujimi   +8 more
semanticscholar   +1 more source